Screening Tests for Renal Impairment in Patients with Type 2 Diabetes: The What, When, and How (Postgraduate Medicine)
The global course of obesity and diabetes presents an alarming forecast for the near future. As the prevalence rates continue to increase and the afflicted population grows younger in age, the associated complications of diabetes will come to pose a greater strain on patients, society, and national health care systems. In recent years, a number of studies have demonstrated the clinical benefits of strict diabetes control in the prevention of debilitating complications, including retinal, renal, and cardiovascular disease. These data highlight the need to maximize our efforts in diabetes prevention and early disease management. Renal dysfunction is a surrogate marker of diabetic microvascular disease, and thus early recognition of renal impa
List Price: $ 9.99
Price: $ 9.99
Screening Tests for Renal Impairment in Patients with Type 2 Diabetes: The What, When, and How (Postgraduate Medicine)
Related Posts:
Orignal From: Screening Tests for Renal Impairment in Patients with Type 2 Diabetes: The What, When, and How (Postgraduate Medicine)
No comments:
Post a Comment